Biosimilar and Biologics Market to Total USD 1,060.7 Billion by 2034 Amid Rising Prevalence of Chronic Diseases and Growing Need for Affordable Treatments | FMI
As per the latest analysis, the biosimilar and biologics market value is estimated to reach